Kevin Wilson

Kevin Wilson is a declared insider of BioSyent Inc., with filings sourced from SEDI. The record holds 8 filings, for trades running from 12 June 2014 to 23 March 2017.

In open-market terms, that means 1 purchase worth €113k on one side and 4 sales worth €57k on the other. No amount is published for 2 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 option exercises. 2017 to date brings 1 purchase and 4 sales.

On 4 April 2017 came the latest disclosure, an open-market sale in BioSyent Inc. The latest purchase dates back some time: it was published 3,498 days ago, on 24 March 2017. Typically, a trade is published a median of 60 days after it takes place. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEDI. Past trades are no guide to future returns.